ここから本文です

次なる飛躍へ。順調な進捗と共に更なる成長の黎明期にて育ちゆく相場。控える材料と共に水準訂正。笑。
予定されていた業績の急成長と共に更なる成長戦略が始動。順調なR&DやPL等の進捗・拡大の加速。笑。
The scope of the opportunity using the Heptares approach extends well beyond our growing Pipeline.
・・・
※HeptaresTL: We are seeking to appoint an enthusiastic and motivated HR Administrator. "Closing 16th January 2017" (1/6)
※Trial Profile: Phase 1, HTL0018318. " Primary Completion (Dec). Planned Study End Date changed from Dec 2016 to Jan 2017" (1/9 update)
※Novartis Reimagining Medicine, JP Morgan Healthcare Conference: "Strong year for breakthrough treatments, Ultibro FLAME data" (1/9)
※Vectura: Pre-close update: "Ultibro continues to benefit from strong data from FLAME as well results of CRYSTAL showing improved lung function" (1/11)
※Vectura-CEO presentation JP Morgan Healthcare Conference: "Utibron & Seebri, US launch expected 2017" (1/11)
※Aukett Swanke Group Final Results: "Notable projects: Biomed Realty building at Granta Park pre let to Heptares" (1/12)
※Drug Profile: Glycopyrrolate/indacaterol. & Glycopyrrolate inhalation - Novartis. (1/12 update)
※Drug Profile: PLX PAD. (1/12 update)
※HeptaresTL: We now seek to recruit a highly motivated GCP Quality Assurance Manager to support Heptares Projects GPCR. "Closing 31st January 2017" (1/13)
・Ensure internal GCP compliance, inspection readiness and to maintain and develop Heptares development quality management systems.
※FiercePharma: Novartis scouts new tech partnerships to build lead on 'risk averse' pharma peers. (1/13)
・The company’s execs think it can be on the “leading edge” in the space. “I think this is an opportunity for us to show our leadership.”
※最終回 四季報プロ500編集部が選んだ新春号の【本命銘柄50】:そーせいグループ (1/14)
・導出先のノバルティス社からのロイヤルティは好調だ。アラガン社からの一時金が剥落する来18年3月期の業績下支えに期待。

※Heptares Careers: We are seeking to appoint an enthusiastic and motivated HR Administrator. "Recruiting End" (1/16)

※Cambridge saw strong 2016 take-up despite uncertainty
16 January, 2017
Take-up in the Cambridge office market hit circa 550,000 sq ft by the end of 2016, broadly in line with the long term average, Savills reports.
Whilst figures were down compared with the same time last year, the city remained resilient in the face of ongoing political uncertainty.
The strong level of take-up, particularly in the second half of the year, was attributed to a number of larger transactions totalling more than 20,000 sq ft.
Deals of this nature included ・・・
Heptares taking 30,000 sq ft at Granta Park, ・・・
ttp://www.businessweekly.co.uk/news/property-and-construction/cambridge-saw-strong-2016-take-despite-uncertainty

・・・
Event
・・・
・2017年(平成29年)3月期 第3四半期決算発表、2017年2月10日
・・・
下期、R&D等の拡充・進捗は着実に進み、年度期末に向けての次なる展開・進捗が楽しみですね。笑。

※SOSEIの成長相場の動向。
・・・
2015/12/25 終値_9670 売残高 _7500 買残高 2282200 ・(2015/12/30 大納会 9950) (2016/1/4 大発会 10300)
12/30 (終値13450) 売残高 __300 買残高 2920000(-126600) 2016大納会 ・(5/9最高値26180、6/24安値12960、11/9安値12510、12/8安値12470)
_1/_6 (終値14030) 売残高 __300 買残高 2907100(_-12900) ・(2017/1/4 大発会 13720)
_1/13 (終値13520) 5日線乖離(-0.53%) 25日線乖離( +0.84%) 75日乖離( -10.21%) 200日線乖離(-21.25%)
_1/16 (終値13310) 5日線乖離(-1.03%) 25日線乖離( -0.54%) 75日乖離( -11.30%) 200日線乖離(-22.40%)

・Technical Analysis Charts (Week)
ttp://www.zonebourse.com/zbcache/charts/ObjectChart.aspx?Name=6814799&Type=Custom&Intraday=1&Width=980&Height=650&Cycle=WEEK1&Duration=61&Render=Candle&ShowName=0&Company=4Traders_us

・Technical Analysis Charts (Day)
ttp://www.4-traders.com/SOSEI-GROUP-CORPORATION-6814799/charts/&applet_mode=statique

・・・

強気相場待ち。時間軸調整後の次なる展開も楽しみです。笑。